20th August 2016

Current Medical Trials

We are currently financially supporting a Phase I Clinical Study to Determine the Optimal Dose for the Safe Immune Restoration and Immune Response of Allogeneic Cell Immunotherapy (ACIT-1) in Adult Cancer Patients.

Full details are at: Investigation of a Therapeutic Vaccine (ACIT-1) in Late Stage Cancer

Please Donate. Your money will go directly to support this trial.